feedzop-word-mark-logo
searchLogin
Feedzop
homeFor YouUnited StatesUnited States
You
bookmarksYour BookmarkshashtagYour Topics
Trending
Terms of UsePrivacy PolicyAboutJobsPartner With Us

© 2026 Advergame Technologies Pvt. Ltd. ("ATPL"). Gamezop ® & Quizzop ® are registered trademarks of ATPL.

Gamezop is a plug-and-play gaming platform that any app or website can integrate to bring casual gaming for its users. Gamezop also operates Quizzop, a quizzing platform, that digital products can add as a trivia section.

Over 5,000 products from more than 70 countries have integrated Gamezop and Quizzop. These include Amazon, Samsung Internet, Snap, Tata Play, AccuWeather, Paytm, Gulf News, and Branch.

Games and trivia increase user engagement significantly within all kinds of apps and websites, besides opening a new stream of advertising revenue. Gamezop and Quizzop take 30 minutes to integrate and can be used for free: both by the products integrating them and end users

Increase ad revenue and engagement on your app / website with games, quizzes, astrology, and cricket content. Visit: business.gamezop.com

Property Code: 5571

Home / Health / Bike Crash Leads to Cancer Scare, Then Diagnosis

Bike Crash Leads to Cancer Scare, Then Diagnosis

10 Jan

•

Summary

  • A bike crash revealed masses in lungs, initially suspected as aggressive cancer.
  • A rare immune condition, IgG4-RD, was finally diagnosed after a year-long search.
  • A new FDA-approved treatment offers hope for remission of IgG4-RD.
Bike Crash Leads to Cancer Scare, Then Diagnosis

A severe mountain bike accident in June 2020 led Andy Provencher to an emergency room, where scans revealed alarming masses in his lungs. Initially suspected to be aggressive lung cancer, this discovery launched a year-long, frustrating diagnostic journey. Provencher consulted numerous specialists, but tests and biopsies remained inconclusive, leaving him and his family in a state of profound uncertainty.

His condition worsened, with increasing pain and energy loss. A breakthrough occurred when a physician's assistant recognized Provencher's symptoms as potentially belonging to IgG4-RD, a rare immune condition. This led him to Dr. John Stone, an expert in IgG4-RD, who finally provided a definitive diagnosis and a treatment plan, alleviating the family's immense stress.

Provencher then participated in a clinical trial for inebilizumab, a medication targeting B cells, which ultimately became the first FDA-approved treatment for IgG4-RD in April 2025. While the disease can go into remission, it has no permanent cure. Provencher continues to take inebilizumab, experiencing significant improvement and hoping to prevent further progression.

Disclaimer: This story has been auto-aggregated and auto-summarised by a computer program. This story has not been edited or created by the Feedzop team.
IgG4-RD is a rare immune condition that can cause inflammation and lesions in various organs. Diagnosis is challenging, often requiring ruling out other diseases and can take years.
The bike crash led to an ER visit where scans revealed lung masses, initiating a suspected cancer diagnosis that was later found to be IgG4-RD.
IgG4-RD can go into remission, but there is no permanent cure. Ongoing treatment, like inebilizumab, aims to manage the condition and prevent relapse.

Read more news on

Healthside-arrow
trending

Ozark Trail stoves recalled

trending

Gale warning issued for Ireland

trending

Svitolina reaches Auckland final

trending

Roblox CEO sells stock

trending

Switzerland reaches United Cup final

trending

Adithya Ashok: New Zealand Squad

trending

Hurkacz leads Poland to title

trending

Wawrinka gets Australian Open wildcard

You may also like

Charlize Theron Tackles Barefoot Climbing in Apex

18 Dec, 2025 • 113 reads

article image

Hitmakers Launch New Label for Artist Longevity

15 Dec, 2025 • 115 reads

article image

Y2K Fears Unleashed: Tech Becomes Terrifying Monsters!

13 Dec, 2025 • 168 reads

article image

Sports Pundits Face 'Defend the Indefensible' Challenge

29 Nov, 2025 • 185 reads

article image

Meta Loses Chief Revenue Officer Amid AI Shake-Up

19 Nov, 2025 • 194 reads

article image